Consun Pharmaceutical Group Limited (HKG:1681)
15.15
-0.57 (-3.63%)
Oct 22, 2026, 3:40 PM HKT
HKG:1681 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, HKG:1681 stock has a consensus rating of "Buy" and an average price target of $22.65. The average 1-year stock price forecast is 49.50% higher than the current stock price, while the lowest is $19.24 (+27.00%) and the highest is $26.01 (+71.68%).
Price Target: $22.65 (+49.50%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 17, 2026.
Analyst Ratings
The average analyst rating for HKG:1681 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Mar '26 | Apr '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DBS | DBS | Buy Maintains $26.00 | Buy | Maintains | $26.00 | +71.62% | Sep 17, 2026 |
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $19.16 | Buy | Maintains | $19.16 | +26.47% | Aug 30, 2026 |
Unknown Analyst China Everbright No rating | China Everbright | Buy Maintains $17.73 | Buy | Maintains | $17.73 | +17.03% | Jul 2, 2026 |
Financial Forecast
Revenue This Year
3.88B
from 3.42B
Increased by 13.60%
Revenue Next Year
4.35B
from 3.88B
Increased by 12.07%
EPS This Year
1.45
from 1.26
Increased by 15.08%
EPS Next Year
1.60
from 1.45
Increased by 10.12%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.